Tackling Prurigo Nodularis (PN): New Treatment Recommendations for Managed Care and Payer Professionals Infographic

Tackling Prurigo Nodularis (PN): New Treatment Recommendations for Managed Care and Payer Professionals Infographic is organized by Impact Education, LLC.

Release Date: April 1, 2024
Expiration Date: October 31, 2025

Statement of Need/Program Overview:
Given the recent FDA approval and expanding pipeline of novel agents, PN treatment recommendations will likely evolve as clinical trial results accumulate and are subsequently translated into clinical practice. Payers may restrict treatment coverage based on clinical trial inclusion/exclusion criteria, requiring patients with PN to have a certain number of lesions and an inadequate treatment response, intolerance, or contraindication to a high potency topical steroid. Based on current practice gaps and barriers, managed care and payer professionals lack knowledge and skills that can help lessen the burden of PN by facilitating patient education, multidisciplinary care, and timely access to appropriate treatments.

Educational Objectives:
After completing this activity, the participant should be better able to:

• Identify the clinical, economic, and social burden of PN
• Review approved and emerging therapies for the treatment of PN including drug targets, route of administration, the latest clinical trial data, and appropriate access to therapy
• Employ multidisciplinary team strategies to improve quality and care coordination for patients with PN